Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains

Raynaud’s Phenomenon is a vascular affliction resulting in pain and blanching of the skin caused by excessive and prolonged constriction of arterioles, usually due to cold exposure. Nifedipine is a vasodilatory calcium channel antagonist, which is used orally as the first-line pharmacological treatm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceutics
Autori principali: Wasan, Ellen K., Zhao, Jinying, Poteet, Joshua, Mohammed, Munawar A., Syeda, Jaweria, Orlowski, Tatiana, Soulsbury, Kevin, Cawthray, Jacqueline, Bunyamin, Amanda, Zhang, Chi, Fahlman, Brian M., Krol, Ed S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920966/
https://ncbi.nlm.nih.gov/pubmed/31717566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110594
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi